BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29563747)

  • 1. Role of RPLND and Metastasectomy in the Management of Oligometastatic Renal Cell Carcinoma.
    Nagaraja H; Srivatsa N; Hemalatha S; Shweta S; Raghunath SK
    Indian J Surg Oncol; 2018 Mar; 9(1):105-109. PubMed ID: 29563747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node dissection in renal cell carcinoma.
    Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
    Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
    Ljungberg B
    Curr Urol Rep; 2013 Feb; 14(1):19-25. PubMed ID: 23212738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review.
    Battaglia A; De Meerleer G; Tosco L; Moris L; Van den Broeck T; Devos G; Everaerts W; Joniau S
    Eur Urol Oncol; 2019 Mar; 2(2):174-188. PubMed ID: 31017094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns.
    Tachibana I; Vasquez R; Mahmoud M; Kern SQ; Patel RS; King J; Adra N; Boris RS; Cary C; Rice KR
    Urol Oncol; 2022 Nov; 40(11):495.e11-495.e17. PubMed ID: 36154800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the role of salvage lymphadenectomy in node only recurrences after nephrectomy for renal cell carcinoma.
    Barboza MP; Speir RW; Boris RS; Calaway AC; Cary C; Foster RS; Masterson TA
    Urol Oncol; 2020 Sep; 38(9):739.e1-739.e8. PubMed ID: 32646691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
    BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic therapy following metastasectomy for renal cell carcinoma: Using insights from other clinical settings to address unanswered questions.
    Appleman LJ; Maranchie JK
    Urol Oncol; 2018 Jan; 36(1):17-22. PubMed ID: 28736252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for overall survival after lung metastasectomy in renal cell cancer patients: A systematic review and meta-analysis.
    Zhao Y; Li J; Li C; Fan J; Liu L
    Int J Surg; 2017 May; 41():70-77. PubMed ID: 28351779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligometastatic head and neck cancer: Comprehensive review.
    Vengaloor Thomas T; Packianathan S; Bhanat E; Albert A; Abraham A; Gordy X; Kanakamedala M; Mehta D; Vijayakumar S
    Head Neck; 2020 Aug; 42(8):2194-2201. PubMed ID: 32220043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic lymph node dissection in lung metastasectomy of renal cell carcinoma: an 18 years of experience.
    Renaud S; Falcoz PE; Alifano M; Olland A; Magdeleinat P; Pagès O; Regnard JF; Massard G
    J Surg Oncol; 2014 Jun; 109(8):823-9. PubMed ID: 24619772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic clear cell renal cell carcinoma in isolated retroperitoneal lymph node without evidence of primary tumor in kidneys: A case report.
    Shields LB; Kalebasty AR
    World J Clin Oncol; 2020 Feb; 11(2):103-109. PubMed ID: 32133279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective analysis of patients undergoing postchemotherapy retroperitoneal lymph node dissection and metastasectomy in advanced nonseminomatous germ cell tumors.
    Malik K; Raja A; Radhakrishnan V; Kathiresan N
    Indian J Urol; 2020; 36(2):112-116. PubMed ID: 32549662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
    Tonyali S; Yazici S
    Int Urol Nephrol; 2016 May; 48(5):671-80. PubMed ID: 26843415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphadenectomy in pulmonary metastasectomy.
    Welter S; Gupta V; Kyritsis I
    J Thorac Dis; 2021 Apr; 13(4):2611-2617. PubMed ID: 34012609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should mediastinal lymphadenectomy be performed during lung metastasectomy of renal cell carcinoma?
    Renaud S; Falcoz PE; Olland A; Massard G
    Interact Cardiovasc Thorac Surg; 2013 Apr; 16(4):525-8. PubMed ID: 23287593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Current Role of Lymph Node Dissection in Nonmetastatic Localized Renal Cell Carcinoma.
    Ngai M; Chandrasekar T; Bratslavsky G; Goldberg H
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synchronous oligometastatic renal cell carcinoma-what is the role of surgery?].
    Ivanyi P; Kuczyk M
    Urologe A; 2021 Dec; 60(12):1546-1554. PubMed ID: 34738151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasectomy with standardized lymph node dissection for metastatic renal cell carcinoma: an 11-year single-center experience.
    Kudelin N; Bölükbas S; Eberlein M; Schirren J
    Ann Thorac Surg; 2013 Jul; 96(1):265-70: discussion 270-1. PubMed ID: 23731615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis therapies for renal cancer.
    Dabestani S; Marconi L; Bex A
    Curr Opin Urol; 2016 Nov; 26(6):566-72. PubMed ID: 27471993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.